Clinical Trial: A Multicenter, Prospective, Open-Label, Randomized Controlled Study Comparing Single-Dose Versus Fractionated-Dose Regimens of Albumin-Bound Paclitaxel in Neoadjuvant Therapy with Toripalimab Combined with Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (China)

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Prospective, Open-Label, Randomized Controlled Study Comparing Single-Dose Versus Fractionated-Dose Regimens of Albumin-Bound Paclitaxel in Neoadjuvant Therapy with Toripalimab Combined with Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131659

Registration Time: 2026/09/04

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Zhengzhou University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=297331

Published by HT Digital Content Services wit...